| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 28 May 2024 | 18 May 2024 |
| Aspira Pathlab & Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2024 inter alia to consider and approve Audited Financial Statements (Standalone) of the Company for the fourth quarter and year ended as on March 31 2024 and to discuss any other matter with the permission of the Chair. Audited Financial Results for the quarter and Financial Year ended March 31, 2024 Appointment of Secretarial Auditor & Internal Auditor of the Company for the Financial Year 2024-2025 (As Per BSE Announcement Dated on 28.05.2024) | ||
| Board Meeting | 13 Feb 2024 | 1 Feb 2024 |
| Aspira Pathlab & Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2024 inter alia to consider and approve Unaudited Financial Results for the quarter and nine months ended December 31 2023 and to consider any other matter with the permission of the Chair. The Board Meeting to be held on 10/02/2024 Stands Cancelled. Aspira Pathlab & Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2024 ,inter alia, to consider and approve Unaudited Financial Results for the quarter ended December 31, 2023 in the Board Meeting to be held on February 13, 2024 and to consider any other business with the permission of the Chair. (As per BSE Announcement Dated on 05/02/2024) Unaudited Financial Results for the quarter and nine months ended December 31, 2023. (As per BSE Announcement Dated on 13/02/2024) | ||
| Board Meeting | 11 Nov 2023 | 28 Oct 2023 |
| Aspira Pathlab & Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2023 inter alia to consider and approve Standalone Unaudited Financial Results for the quarter and half year ended as on September 30 2023 Financial Results for the Second Quarter and Half Year Ended 30th September,2023 duly approved by the Audit Committee and Board Meeting in its meeting held on November 11, 2023 (As Per BSE Announcement Dated on 11.11.2023) Newspaper Advertisement for Unaudited Financial Results for the quarter and the half year ended September 30, 2023 (As Per BSE Announcement Dated on 13/11/2023) | ||
| Board Meeting | 12 Aug 2023 | 26 Jul 2023 |
| Aspira Pathlab & Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2023 inter alia to consider and approve the Unaudited Financial Results of the Company for the Quarter ended 30th June 2023 and to consider any other business with the permission of the Chair. ASPIRA PATHLAB & DIAGNOSTICS LIMITED has informed BSE about Board Meeting to be held on 12 Aug 2023 to consider financial statements for the period ended June 2023. Financial results. Approval of the Financial Results and Limited Review Report for the quarter ended June 30, 2023 Appointment of Mr. Manas Mengar as the Additional Independent, Non-Executive Director of the Company for the period of 5 (Five) Years subject to the approval of members in the General Meeting The Board of Directors in its meeting held today has approved the appointment of Ms. Krupali Shah as the Company Secretary and Compliance Officer of the Company Pursuant to regulation 30 of the SEBI (LODR) Regulations, 2015 the Board of Directors in its meeting held today had discussed following two items 1)To increase the promoter stake in the Company via Open Offer 2) To increase the business tie ups with the Promoter Company M/s. Yashraj Biotechnology Limited However the above items were only discussed in the meeting and shall be finalized only once the formal agreement are acted upon. Further the finalized decisions with respect to above items shall be informed to the Stock Exchange on time to time basis (As per BSE Announcement Dated on 12/08/2023) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Securities Ltd. All Rights Reserved
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
